The CARD11-BCL10-MALT1 signaling complex is a pivotal regulator of NF-κB activation in CLL, and its dysregulation has been implicated in promoting resistance to therapies targeting BCR signaling. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.